A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction

Richards, 1984, A review of its antibacterial activity, pharmacological properties and therapeutic use, Drugs, 27, 469, 10.2165/00003495-198427060-00001 Riccabona, 1993, Ceftriaxone-induced cholelithiasis − a harmless side-effect?, Klin Padiatr, 205, 421423 Palanduz, 2000, Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children, J Clin Ultrasound, 28, 166, 10.1002/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G Schaad, 1998, Reversible ceftriaxone-associated biliary pseudolithiasis in children, Lancet, 2, 1411 Kimura, 2006, Clinical features of ceftriaxone-associated biliary pseudolithiasis in children, Nihon Shonika Gakkkai Zassi (J Jpn Pediatr Soc), 110, 773 Schiffman, 1990, Pathogenesis of ceftriaxone − associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility, Gastroenterology, 99, 1772, 10.1016/0016-5085(90)90486-K Brogard, 1988, High biliary elimination of ceftriaxone in man, Int J Clin Pharmacol Ther Toxicol, 26, 167 Biner, 2006, Ceftriaxone-associated biliary pseudolithiasis in children, J Clin Ultrasound, 34, 217, 10.1002/jcu.20228 McNamara, 1982, Pharmacokinetics of ceftriaxone following intravenous administration of a 3g dose, Eur J CIin Pharmacol, 22, 71, 10.1007/BF00606428 Papadopoulou, 1999, Incidence of ceftriaxone-associated gallbladder pseudolithiasis, Acta Paediatr, 88, 1352, 10.1111/j.1651-2227.1999.tb01050.x Robertson, 1996, Ceftriaxone choledocholithiasis, Pediatrics, 98, 133, 10.1542/peds.98.1.133 Murata, 2015, Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolithiasis, Pediatr Int, 57, 942, 10.1111/ped.12625 Araz, 2007, Pseudolithiasis due to ceftriaxone treatment for meningitis in children: Report of 8 cases, Tohoku J Exp Med, 211, 285, 10.1620/tjem.211.285 Cohen, 1983, Pharmacokinetics of ceftriaxone in patients with renal failure and those undergoing hemodialysis, Antimicrob Agents Chemother, 24, 529, 10.1128/AAC.24.4.529